Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients
Mediterr J Hematol Infect Dis
.
2020 Jul 1;12(1):e2020048.
doi: 10.4084/MJHID.2020.048.
eCollection 2020.
Authors
Claudio Ucciferri
1
2
,
Mirko Barone
3
,
Jacopo Vecchiet
1
,
Katia Falasca
1
Affiliations
1
Clinic of Infectious Diseases - Department of Medicine and Science of Aging, University "G. d'Annunzio" Chieti-Pescara- Italy.
2
Department of Medicine and Health Sciences, University of Molise - Campobasso - Italy.
3
Department of General and Oncological Surgery, University Hospital of Chieti, Chieti, Italy.
PMID:
32670526
PMCID:
PMC7340237
DOI:
10.4084/MJHID.2020.048
No abstract available
Keywords:
COVID-19; Immunomodulatory; Safety; Treatment.